Abstract: Disclosed is a means effective for the treatment or prevention of inflammatory bowel disease. Specifically disclosed is an enzyme composition for the treatment or prevention of inflammatory bowel disease, which utilizes an enzyme capable of producing an oligosaccharide in vivo.
Abstract: A crystalline sialon comprising crystals containing aluminum, silicon, nitrogen and oxygen, in which the crystal structure has a hexagonal system wurtzite structure identical with that of AlN crystals, and the volume of the unit cell thereof has a value smaller than that of the AlN crystals. The crystalline sialon can be synthesized by mixing a silicon-containing gas, an aluminum halide, a nitrogen atom-containing gas and an oxygen atom-containing gas, converting the gas mixture into plasmas by microwave discharging and depositing a film on the surface of a substrate, in which the temperature of the substrate, while controlling a flow rate of the silicon-containing gas and a flow rate of the oxygen-containing gas. The crystalline sialon of the present invention has high hardness, is excellent in oxidation resistance, as well as excellent in heat conductivity and adhesion with a superhard substrate.
Type:
Grant
Filed:
October 12, 1993
Date of Patent:
July 4, 1995
Assignees:
Alps Electric Co., Ltd., Toshio Hirai, Makoto Sasaki
Abstract: A carbon/carbon composite having oxidation resistance is produced by filling the voids of a carbon/carbon composite comprising 10-70% by volume of carbon fibers and 5-90% by volume of a carbonaceous matrix and having a void percentage of 10-55%, with at least one of carbon and a ceramic by chemical vapor infiltration and then coating the deposit surface with a ceramic or both ceramic and carbon by chemical vapor deposition.
Type:
Grant
Filed:
March 29, 1989
Date of Patent:
September 3, 1991
Assignees:
Nippon Oil Company, Limited, Toshio Hirai, Makoto Sasaki, Japan as represented by the Director-General National, Aerospace Laboratory